KomturKomtur_Logo.svg
Contact

Patient-Specific Access When a Therapy Isn’t Marketed Locally

Breakthroughs rarely launch everywhere at once. When a therapy is approved in another region but not marketed locally, treatment plans face a gap. Individual Import closes that gap by converting external approvals into patient-specific (named-patient) access at the point of care. We source the required presentation from licensed supply in approved regions and hand over to the hospital pharmacy under the applicable country provisions, so clinically justified patients can receive innovation safely and in compliance.

Individual Import is the bridge between global innovation and local care. It serves rare, niche, and specialty settings where suitable local options are absent, turning recently approved therapies from other regions into real choices for individual patients. Built for clinical reality, it keeps medical need at the center, supports hospital governance, and protects product integrity through to confirmed site receipt. For clinicians, it expands therapeutic options. For pharmacies, it provides a clear, auditable path. For patients, it helps keep treatment moving without waiting for commercialization.

About Individual Import

When the right therapy exists elsewhere but not here, Individual Import makes that innovation locally actionable for a single, clinically justified patient. Built for specialty centers and hospital pharmacies, it translates nonmarketed, externally approved therapies into named-patient access at the point of care, with clear clinical rationale, a country-appropriate route, and a pharmacy-ready handover.

The result is a true extension of therapeutic choice, creating another chance for the individual patient.

  • Access to global innovation

    Case-by-case access to therapies approved in other regions when suitable local options are absent or unsuitable.

  • Exact presentation, planned continuity

    Source the required form, strength, and pack, and set a resupply cadence to support ongoing treatment courses.

  • Clinically governed, patient-first

    Access grounded in medical need and aligned with hospital committees for transparent, defensible decisions.

  • Predictable case lifecycle

    Clear milestones from request to confirmed site receipt, plus renewal reminders, expiration monitoring, and scheduled deliveries aligned with clinics.

  • Integrity to the point of care

    Licensed sourcing with serialization and batch and lot traceability, delivered temperature-controlled to protect product quality.

  • Transparent cost & procurement fit

    Upfront quotes with duties, taxes, and logistics accounted for, compatible with hospital purchasing and budget workflows.

  • Multi-site repeatability

    Standardized workflow that works the same way across departments and hospitals, reducing variation and effort.

Our Named Patient Import Services

Why Komtur?

  • Patient-first, care-centric handling

    Single case owner, transparent status, and checklist documentation helps keep cases moving and care continuous.

  • Speed with certainty

    Bonded-warehouse release, established customs and IOR workflows, as well as temperature-controlled last-mile to receipt by hospital or pharmacy .

  • Licensed global access network:

    Quality-assured sourcing with falsified-medicines safeguards, serialization, and end-to-end batch traceability.

  • Authority-aligned, multi-country enablement.

    Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance, and documentation support.

  • Proactive access insights.

    Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.

“When a medicine exists but isn’t available locally, we make it possible for the hospital to say yes. That’s the power of individual import.”